Ruffer Investment Company (LON:RICA) released its Annual Financial Report for the year ended June 30, 2025. In this article quoting directly from the Chair’s statement in its Strategic Report, we’ve covered the key performance indicators, investment performance, fund managers, earnings and dividends and outlook...
Big Technologies plc (AIM: BIG) has confirmed that Alexander Brennan has stepped down as Independent Non-Executive Chair with immediate effect. Sangita Shah has been appointed Interim Chair as the company continues efforts to resolve ongoing litigation with former CEO Sara Murray...
FW Thorpe reported preliminary results for the year to 30 June 2025, with profit before tax up 5.9% to £31.6 million and earnings per share rising 4.6% to 21.69p...
Manx Financial has released its presentation covering unaudited interim results for the six months to 30 June 2025. The update outlines financial performance, operational highlights, and strategic developments, including growth in profit before tax to £4.1 million and earnings per share rising to 3.11 pence..
Hercules plc expects FY25 revenue above £118m, up 16% year-on-year, with adjusted EBITDA and PBT in line with market forecasts. Growth was driven by UK infrastructure investment, acquisitions including Advantage NRG, and expansion of the Hercules Academy...
Avation Plc reported FY2025 revenue of $110.1m, up 19.2%, and EBITDA of $107.1m. The company posted a $7.7m loss after tax, reduced net indebtedness to $604.2m, and declared a 1.0 US cent dividend...
Ampeak Energy, in partnership with Econergy, has received conditional planning permission from Newport City Council for the 250MW/1250MWh Afon Wysg 2 battery storage project at the Uskmouth Sustainable Energy Park...
Tekmar Group has won a $1.5 million contract with an existing EPC customer to supply engineered scour protection solutions and specialised installation equipment...
Diversified Energy Company has announced plans to move its primary listing to the New York Stock Exchange while maintaining a secondary listing on the London Stock Exchange...
Cizzle Biotechnology is now in commercial motion, with its lung cancer diagnostic test entering clinical validation across North America. Backed by Cizzle Bio, OmniHealth, and the Moffitt Cancer Center, the company is moving from lab bench to nationwide rollout — with royalty payments already in hand...
Mark Thomas of Hardman & Co explains why Arbuthnot’s profit drop isn’t the full story — and where the real value creation is happening across its wealth, deposits, and specialist lending arms...
CEO Graeme Purdy shares a pivotal update on the company’s Stereax micro batteries as they complete manufacturing qualification and move into production...
EDX Medical Group Plc has joined forces with leading NHS and government health bodies to deliver a rapid hospital-acquired pneumonia test. Sir Chris Evans explains why this partnership could change patient outcomes, cut costs, and accelerate the UK’s precision medicine agenda...
TEAM plc Executive Chairman Mark Clubb has given an interview with DirectorsTalk, outlining the firm’s UCITS fund launch, HY25 interim results, and future outlook...
Vassilios Carellas breaks down the decision to raise equity now, the operational breakthroughs at Kiln 1, and how upcoming upgrades to Kilns 2, 3, and 4 aim to cement the company’s critical role in quicklime production..
CEO Andrew Hume walks us through a significant new agreement with Metals One, a deal that brings in capital and specialist partners while allowing Thor to retain upside exposure..
Stephane Foucaud of Auctus Advisors reveals how robust execution and a cash-rich balance sheet are fuelling both growth and shareholder value. Investors should keep Valeura firmly on their radar...
Legal & General Group announced that Jeff Davies will step down as Group CFO after eight years, with Andrew Kail appointed as his successor effective 1 December 2025, subject to regulatory approval...
GSK has announced the appointment of Luke Miels as CEO Designate, with full responsibilities and a Board position from 1 January 2026. Currently Chief Commercial Officer, Luke has been key in expanding GSK’s specialty medicines and vaccines portfolio, bringing senior experience from AstraZeneca, Roche and Sanofi-Aventis...
Berkeley Group has announced the appointment of Neil Eady to its board as Chief Financial Officer. Neil, who joined Berkeley in 2013, has held several senior finance roles within the Group, including his work on establishing the St William joint venture...
Babcock International Group announced a positive trading update for the five months to 31 August 2025, with organic revenue growth and margin progress in line with expectations...
3i Group will host a Capital Markets Seminar today, providing updates on portfolio performance, realisations and new investments. The group reported resilient progress across both Private Equity and Infrastructure, including the sale of MAIT for gross proceeds of around £143 million, representing a 30% uplift on its March 2025 valuation...
Halma plc reported strong progress in the first half of its financial year to 30 September 2025, raising full-year revenue growth guidance to low double-digit organic constant currency growth, up from upper single digits...
Aston Martin expects 2025 wholesale volumes to fall by a mid-to-high single digit percentage versus last year, with adjusted EBIT now forecast below consensus...
J D Wetherspoon has announced preliminary results for the 52 weeks to 27 July 2025. Revenue rose 4.5% to £2.13 billion, with profit before tax up 10.1% to £81.4 million. Earnings per share increased 4.5% to 50.8p, while free cash inflow per share almost doubled to 47.3p. The full-year dividend remains at 12.0p...
Morgan Sindall Group said it now expects full year 2025 results to be significantly ahead of previous guidance, supported by continued strength in its Fit Out division...